PanCancer IO 360™ Panel Breast Cancer 360™ Panel Tumor Signaling 360 Panel CD3/CD4/CD8 Naive & Memory Markers NK Cell Markers Measure shifts in TCR diversity in response to disease or therapeutic treatments, simultaneously measure TCR diversity and T cell phenotype with a streamlined workflow Obtain a report with a TCR diversity score for each sample CD3/CD4/CD8 Naive & Memory Markers NK Cell Markers Measure shifts in TCR diversity in response to disease or therapeutic treatments, simultaneously measure TCR diversity and T cell phenotype with a streamlined workflow Obtain a report with a TCR diversity score for each sample CD3/CD4/CD8 Naive & Memory Markers NK Cell Markers Measure shifts in TCR diversity in response to disease or therapeutic treatments, simultaneously measure TCR diversity and T cell phenotype with a streamlined workflow Obtain a report with a TCR diversity score for each sample CD3/CD4/CD8 Naive & Memory Markers NK Cell Markers Measure shifts in TCR diversity in response to disease or therapeutic treatments, simultaneously measure TCR diversity and T cell phenotype with a streamlined workflow Obtain a report with a TCR diversity score for each sample Optimize CAR-T method development Create manufacturing acceptance criteria Measure metabolic fitness and persistence Monitor post-infusion exhaustion and toxicity Comprehensive gene expression analysis of cancer progression Quantify gene expression of metastatic growth and suppressor genes Rapidly and easily screen samples for biomarker discovery or drug mechanism of action to support your research 
Profile 800 genes across 47 annotated pathways involved in canine immune response to IO treatments Overlapping content with NanoString’s Human PanCancer IO 360 and PanCancer Immune Profiling Panels provides a suite of panels for comparative studies PanCancer coverage with tumor specific content for top canine cancers including Melanoma, Osteosarcoma, Lymphoma, Urothelial Carcinoma, and Glioblastoma. 
Ideal for the study of allergy, autoimmune diseases, and the immune response to infectious disease Unique mouse genes address known differences such as unique receptor ligands, Ig receptors and chemokines Over 500 general immunology genes. Therapeutic mechanism of action (MOA) studies Immunotherapy-induced adverse event investigations Discovery/validation of disease and therapeutic specific biomarkers Development of predictive signatures of drug response Compatible with challenging sample types such as PBMCs and FFPE Mechanisms of immune evasion Damage response, wound healing & tissue repair Immune regulation Disease pathogenesis Treatment response vs. non-response Study the immune response to transplanted tissue Discover biomarkers for organ rejection and tissue damage for kidney, heart, liver, and lung Evaluate immunosuppressive drug pathways Understand mechanisms behind drug-induced toxicity Identify BK Polyomavirus, Cytomegalovirus, and Epstein-Barr virus Quantify the relative abundance of 14 different immune cells Content useful for the study of asthma, allergy, arthritis, and neurological-related inflammation Coverage of anti-inflammatory drugs that modulate the inflammatory response Overlapping coverage between Human and Mouse panels for direct species comparison Elucidate the mechanism of action behind the four stages of fibrosis: initiation, inflammation, proliferation, and modification Understand the signaling cascade from cell stress to inflammation Quantify the relative abundance of 14 different immune cell types 
Host Susceptibility Interferon Response Innate Immune Cell Activation Adaptive Immune Response Homeostasis Develop signatures of host response dynamics Immune Activation Immune Suppression Immune Status Immune Checkpoints Epigenetics Metabolism & Microenvironment Mechanisms of immune evasion Damage response, wound healing & tissue repair Immune regulation Disease pathogenesis Treatment response vs. non-response 
Cell stress & Damage Response Pathways Regulating Glia Inflammation & Peripheral Immune Invasion Glial Cell Homeostasis & Activation Neurotransmission Quantify the relative abundance of 5 CNS cell types and 14 peripheral immune cells Gene expression profiling of neuroimmune interactions The study of drug treatment response and signature generation Biomarker characterization Research of neurodegenerative disease, traumatic brain injury, psychiatric disorders, neuropathic pain, CNS infection, and others Developed for research of Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Huntington's Disease, and other neurological disorders Includes unique cell typing feature for measuring the abundance of five important CNS cell types, including neurons, astrocytes, microglia, oligodendrocytes, and endothelial cells 770 gene made-to-order panel for human or mouse built as a Custom CodeSet Comprehensive assessment of 30 AD-associated gene co-expression modules including 23 neurodegeneration pathways and processes Reproducible monitoring of AD progression with age Functional screening of potential AD therapeutics AD characterization customizable with up to 55 additional user-defined genes with Panel Plus option 
Study processes known to impact gene therapy development and manufacturing Understand factors influencing optimal gene therapy development and manufacturing Monitor for toxicities Quantify the presence and relative abundance of different immune cell types present during therapy Customize to incorporate therapy specific biology, enabling parallel monitoring of therapy and host response biology Stemness Pluripotency Regulatory Signaling Epigenetics Mechano-Signaling Metabolism Differentiation Signaling Lineage Specification 
Cardiovascular Pathology Cardiovascular Physiology Vascular Inflammation Cellular Aging & Renewal Metabolism Mechano Signaling Regulatory Signaling Epigenetic Remodeling 
